Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

A randomized study on donor immunization with tetanus–diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation

Abstract

The HLA-identical sibling donors of 111 bone marrow transplantation (BMT) recipients were randomised to receive or not to receive tetanus–diphtheria (T–d), Haemophilus influenzae type b (Hib), and inactivated poliovirus (IPV) vaccines 2–10 weeks before BM harvest. Fifty-three (DV+ group) recipients received the graft from a vaccinated donor and 58 (DV− group) from an unvaccinated donor. All recipients were vaccinated with the T–d, Hib and IPV vaccines at 3, 6 and 12 months after BMT. Diphtheria and Hib antibody concentrations were consistently higher in the DV+ than in the DV− group from 6 months post transplantation onwards. The differences were significant at 6 and 13 months for diphtheria and at 12 months for Hib antibody concentrations. Tetanus, PV1, PV2 and PV3 antibody levels were similar in both groups. Patients transplanted from donors with high tetanus, diphtheria and Hib antibody concentrations had higher respective antibody concentrations after BMT than those transplanted from donors with low antibody concentrations. Especially patients whose donors have low-specific antibody concentrations may benefit from donor vaccination with protein and conjugate vaccines.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Atkinson K . Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant 1990; 5: 209–226.

    CAS  PubMed  Google Scholar 

  2. Ljungman P, Wiklund-Hammarsten M, Duraj V, Hammarström L, Lönnqvist B, Paulin T et al. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis 1990; 162: 496–500.

    Article  CAS  Google Scholar 

  3. Engelhard D, Handsher R, Naparstek E, Hardan I, Strauss N, Aker M et al. Immune response to polio vaccination in bone marrow transplant recipients. Bone Marrow Transplant 1991; 8: 295–300.

    CAS  PubMed  Google Scholar 

  4. Ljungman P, Duraj V, Magnius L . Response to immunization against polio after allogeneic marrow transplantation. Bone Marrow Transplant 1991; 7: 89–93.

    CAS  PubMed  Google Scholar 

  5. Barra A, Cordonnier C, Preziosi M-P, Intrator L, Hessel L, Fritzell B et al. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. J Infect Dis 1992; 166: 1021–1028.

    Article  CAS  Google Scholar 

  6. Li Volti S, Mauro L, Di Gregorio F, Romeo MA, Lupo L, Pizzarelli G et al. Immune status and immune response to diphtheria-tetanus and polio vaccines in allogeneic bone marrow-transplanted thalassemic patients. Bone Marrow Transplant 1994; 14: 225–227.

    CAS  PubMed  Google Scholar 

  7. Parkkali T, Ruutu T, Stenvik M, Kuronen T, Käyhty H, Hovi T et al. Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation. APMIS 1996; 104: 383–388.

    Article  CAS  Google Scholar 

  8. Parkkali T, Käyhty H, Ruutu T, Volin L, Eskola J, Ruutu P . A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT. Bone Marrow Transplant 1996; 18: 961–967.

    CAS  PubMed  Google Scholar 

  9. Parkkali T, Ölander R-M, Ruutu T, Vuontela K, Volin L, Eskola J et al. A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT. Bone Marrow Transplant 1997; 19: 933–938.

    Article  CAS  Google Scholar 

  10. Parkkali T, Stenvik M, Ruutu T, Hovi T, Volin L, Ruutu P . Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT. Bone Marrow Transplant 1997; 20: 663–668.

    Article  CAS  Google Scholar 

  11. Vance E, George S, Guinan EC, Wheeler C, Antin JH, Ambrosino DM et al. Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation. Bone Marrow Transplant 1998; 22: 735–741.

    Article  CAS  Google Scholar 

  12. Storek J, Ferrara S, Ku N, Giorgi JV, Champlin RE, Saxon A . B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant 1993; 12: 387–398.

    CAS  PubMed  Google Scholar 

  13. Wimperis JZ, Brenner MK, Prentice HG, Thompson EJ, Hoffbrand AV . B cell development and regulation after T cell-depleted marrow transplantation. J Immunol 1987; 138: 2445–2450.

    CAS  PubMed  Google Scholar 

  14. Molrine DC, Guinan EC, Antin JH, Parsons SK, Weinstein HJ, Wheeler C et al. Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation. Blood 1996; 87: 3012–3018.

    CAS  PubMed  Google Scholar 

  15. Molrine DC, Antin JH, Guinan EC, Soiffer RJ, MacDonald K, Malley R et al. Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. Blood 2003; 101: 831–836.

    Article  CAS  Google Scholar 

  16. Atkinson K, Storb R, Prentice RL, Weiden PL, Witherspoon RP, Sullivan K et al. Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 1979; 53: 720–731.

    CAS  PubMed  Google Scholar 

  17. Cordonnier C, Bernaudin J-F, Bierling P, Huet Y, Vernant J-P . Pulmonary complications occurring after allogeneic bone marrow transplantation. A study of 130 consecutive transplanted patients. Cancer 1985; 58: 1047–1054.

    Article  Google Scholar 

  18. Aucouturier P, Barra A, Intrator L, Cordonnier C, Schulz D, Duarte F et al. Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. Blood 1987; 70: 779–785.

    CAS  PubMed  Google Scholar 

  19. Wingard JR . Advances in the management of infectious complications after bone marrow transplantation. Bone Marrow transplant 1990; 6: 371–383.

    CAS  PubMed  Google Scholar 

  20. Lossos IS, Breuer R, Or R, Strauss N, Elishoov H, Naparstek E et al. Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study. Transplantation 1995; 60: 672–678.

    Article  CAS  Google Scholar 

  21. Peltola H . Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: Global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000; 13: 302–317.

    Article  CAS  Google Scholar 

  22. Heath PT, McVernon J . The UK Hib vaccine experience. Arch Dis Child 2002; 86: 396–399.

    Article  CAS  Google Scholar 

  23. Garner D, Weston V . Effectiveness of vaccination for Haemophilus influenzae type b. Lancet 2003; 361: 395–396 (research letter).

    Article  Google Scholar 

  24. Ruutu T, Volin L, Parkkali T, Juvonen E, Elonen E . Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study. Blood 2000; 96: 2391–2398.

    CAS  PubMed  Google Scholar 

  25. Thomas ED, Storb R, Clift RA, Feder A, Johnson FL, Neiman PE et al. Bone marrow transplantation (second of two parts). New Engl J Med 1975; 292: 895–902.

    Article  CAS  Google Scholar 

  26. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217.

    Article  CAS  Google Scholar 

  27. Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267–276.

    CAS  PubMed  Google Scholar 

  28. Rapola S . The Finnish vaccination schedule was reformed at the beginning of the year 2005 (In Finnish). Tabu 2005; 1: 4–6.

    Google Scholar 

  29. Kristiansen M, Aggerbeck H, Heron I . Improved ELISA for determination of anti- diphtheria and/or anti-tetanus antitoxin antibodies in sera. APMIS 1997; 105: 843–853.

    Article  CAS  Google Scholar 

  30. Mäkelä PH, Käyhty H, Leino T, Auranen K, Peltola H, Ekström N et al. Long-term persistence of immunity after immunisation with Haemophilus influenzae type b conjugate vaccine. Vaccine 2003; 22: 287–292.

    Article  Google Scholar 

  31. Käyhty H, Peltola H, Karanko V, Mäkelä PH . The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983; 147: 1100.

    Article  Google Scholar 

  32. Fernandez J, Levine OS, Sanchez J, Balter S, LaClaire L, Feris J et al. Prevention of Haemophilus influenzae type b colonization by vaccination: Correlation with serum anti-capsular IgG concentration. J Infect Dis 2000; 182: 1553–1556.

    Article  CAS  Google Scholar 

  33. Albrecht P, van Steenis G, van Wezel AL, Salk J . Standardization of poliovirus neutralizing antibody tests. Rev Infect Dis 1984; 6 (S2): S540–S544.

    Article  Google Scholar 

  34. Storek J, Dawson MA, Lim LC-L, Burman BE, Stevens-Ayers T, Viganego F et al. Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation. Bone Marrow Transplant 2004; 33: 337–346.

    Article  CAS  Google Scholar 

  35. Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. New Engl J Med 1995; 332: 143–149.

    Article  CAS  Google Scholar 

  36. Weinberg K, Annett G, Kashyap A, Lenarsky C, Forman SJ, Parkman R . The effect of thymic function on immunocompetence following bone marrow transplantation. Biol Blood Marrow Transplant 1995; 1: 18–23.

    CAS  PubMed  Google Scholar 

  37. Ottinger HD, Beelen DW, Scheulen B, Schaefer UW, Grosse-Wilde H . Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 1996; 88: 2775–2779.

    CAS  PubMed  Google Scholar 

  38. Charbonnier A, Sainty D, Faucher C, Arnoulet C, Chabannon C, Blaise D . Immune reconstitution after blood cell transplantation. Hematol Cell Ther 1997; 39: 261–264.

    Article  CAS  Google Scholar 

  39. Pavletic ZS, Joshi SS, Pirruccello SJ, Tarantolo SR, Kollath J, Reed EC et al. Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies. Bone Marrow Transplant 1998; 21: 33–41.

    Article  CAS  Google Scholar 

  40. Storek J, Dawson MA, Storer B, Stevens-Ayers T, Maloney DG, Marr KA et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001; 97: 3380–3389.

    Article  CAS  Google Scholar 

  41. Saxon A, Mitsuyasu R, Stevens R, Champlin RE, Kimata H, Gale RP . Designed transfer of specific immune responses with bone marrow transplantation. J Clin Invest 1986; 78: 959–967.

    Article  CAS  Google Scholar 

  42. Guinan EC, Molrine DC, Antin JH, Lee MC, Weinstein HJ, Sallan SE et al. Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation 1994; 57: 677–684.

    Article  CAS  Google Scholar 

  43. Engelhard D, Cordonnier C, Shaw PJ, Parkkali T, Guenther C, Martino R et al. Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey. Br J Haematol 2002; 117: 444–450.

    Article  Google Scholar 

  44. Ljungman P, Aschan J, Gustafsson B, Lewensohn-Fuchs I, Winiarski J, Ringdén O . Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients. Bone Marrow Transplant 2004; 34: 1067–1069.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Ritva Keskimäki and Sari Haavisto for vaccinating the donors and patients and for organising the collection of serum samples.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T Parkkali.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parkkali, T., Käyhty, H., Hovi, T. et al. A randomized study on donor immunization with tetanus–diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation. Bone Marrow Transplant 39, 179–188 (2007). https://doi.org/10.1038/sj.bmt.1705562

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705562

Keywords

This article is cited by

Search

Quick links